Abstract:BackgroundWhen initiating therapy with synthetic disease-modifying anti-rheumatic drugs (sDMARDs) in patients with rheumatoid arthritis (RA), the recommended target is remission or low disease activity (LDA). Limited data exist on the impacts of reaching remission rather than LDA on long-term outcomes.ObjectivesTo compare RA-patients who achieved Simplified Disease Activity Index (SDAI) remission versus LDA 6 months after initiating sDMARD therapy, with regard to physical function, Health Related Quality of Li… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.